Summit Therapeutics Plc Stock In The News
| SMMT Stock | USD 22.36 0.72 3.33% |
Our overall analysis of Summit Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Summit Therapeutics PLC. The specific impact of Summit Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Summit Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Summit Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Summit Therapeutics Backtesting and Summit Therapeutics Hype Analysis.
Summit |
Summit Therapeutics Today Top News and Investor Outlook
Summit Therapeutics PLC Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Summit and other traded companies coverage with news coverage. We help investors stay connected with Summit headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on Summit Stock performance. Please note that trading solely based on the Summit Therapeutics PLC hype is not for everyone as timely availability and quick action are needed to avoid losses.
Summit Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Summit earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Summit Therapeutics that are available to investors today. That information is available publicly through Summit media outlets and privately through word of mouth or via Summit internal channels. However, regardless of the origin, that massive amount of Summit data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Summit Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Summit Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Summit Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Summit Therapeutics alpha.
Summit Largest EPS Surprises
Earnings surprises can significantly impact Summit Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-30 | 2024-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2024-08-06 | 2024-06-30 | -0.06 | -0.09 | -0.03 | 50 | ||
2019-06-26 | 2019-03-31 | -0.16 | -0.2 | -0.04 | 25 | ||
2017-06-14 | 2017-03-31 | -0.17 | -0.096 | 0.074 | 43 | ||
2019-03-27 | 2018-12-31 | -0.24 | -0.35 | -0.11 | 45 | ||
2019-12-17 | 2019-09-30 | -0.4 | -0.22 | 0.18 | 45 |
Summit Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Summit Therapeutics PLC Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
30th of January 2025
Up More Than 500 percent in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock - s... at news.google.com
21st of January 2025
Why Summit Therapeutics Stock Is Jumping Today at fool.com
16th of January 2025
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 at businesswire.com
15th of January 2025
Why Summit Therapeutics Rocketed 584 percent in 2024 at finance.yahoo.com
7th of January 2025
Summit Therapeutics Inc to Present at J.P. Morgan Healthcare Conference at gurufocus.com
23rd of December 2024
Is Summit Therapeutics Inc. the Best Performing Biotech Stock in 2024 at finance.yahoo.com
21st of November 2024
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 at businesswire.com
Summit Therapeutics Investors Sentiment
The influence of Summit Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Summit. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Summit Therapeutics' public news can be used to forecast risks associated with an investment in Summit. The trend in average sentiment can be used to explain how an investor holding Summit can time the market purely based on public headlines and social activities around Summit Therapeutics PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Summit Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Summit Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Summit Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Summit Therapeutics.
Summit Therapeutics Implied Volatility | 1.09 |
Summit Therapeutics' implied volatility exposes the market's sentiment of Summit Therapeutics PLC stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Summit Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Summit Therapeutics stock will not fluctuate a lot when Summit Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Summit Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Summit Therapeutics' short interest history, or implied volatility extrapolated from Summit Therapeutics options trading.
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.